• 1
    Unwin C, Blatchley N, Coker W et al. Health of UK servicemen who served in the Persian Gulf War. Lancet 1999; 353: 16978.
  • 2
    Persian Gulf Veterans Coordinating Board. Unexplained illnesses among Desert Storm veterans. A search for causes, treatment, and cooperation. Arch Inter Med 1995; 155: 2628.
  • 3
    Haley R, Kurt TL. Self reported exposure to neurotoxic chemical combinations in the Gulf War. A cross-sectional epidemiological study. J Am Assoc 1997; 277: 2317.
  • 4
    Abou-Donia MB, Wilmarth KR, Jensen KF, Oehme FW, Kurt TL. Neurotoxicity resulting from coexposure to pyridostygmine bromide, deet and permethrine: Implications of Gulf War chemical exposure. J Toxicol Environ Health 1996; 48: 3556.
  • 5
    Hyams KC, Wignall S, Roswell R. War syndromes and their evaluation: From the U.S. Civil War to the Persian Gulf War. Ann Inter Med 1996; 125: 398405.
  • 6
    Rook G, Zumla A. Gulf war syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile? Lancet 1997; 349: 18313.
  • 7
    Grady EP, Carpenter M, Koening C, Older S, Battafarano DF. Rheumatic findings in Gulf War veterans. Arch Intern Med 1998; 158: 36771.
  • 8
    Black D, Doebbeling B, Voelker M et al. Multiple chemical sensitivity syndrome. symptom prevalence and risk factors in a military population. Arch Intern Med 2000; 160: 116976.
  • 9
    Reid S, Hotopf M, Hull L, Ismail K, Unwin C, Wessely S. Multiple chemical sensitivity and chronc fatigue syndrome in UK Gulf War veterans. Am J Epidemiol 2001; 153: 6049.
  • 10
    Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins J, Komaroff A, The International Chronic Fatigue Syndrome Study Group. The chronic fatigue syndrome. a comprehensive approach to its definition and study. Ann Inter Med 1994; 121: 9539.
  • 11
    Sharpe M, Archard LC, Banatvala JE et al. A report – chronic fatigue syndrome: guidelines for research. J R Soc Med 1991; 84: 11821.
  • 12
    Wessely S, Chalder T, Hirsch S, Wallace P, Wright D. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health 1997; 87: 144955.
  • 13
    Konstantinov K, Von Mikecz A, Buchwald D, Jones J, Gerace L, Tan EM. Autoantibodies to Nuclear Envelope Antigens in Chronic Fatigue Syndrome. J Clin Invest 1996; 98: 188896.
  • 14
    Nesher G, Margalit R, Ashkenazi YJ. Anti-Nuclear Envelope Antibodies. Clin Assocs Sem Arth Rheum 2001; 30: 31320.
  • 15
    McKeon FD, Tuffanelli DL, Fukuyama K, Kirschner MW. Autoimmune response directed against conserved determinants of nuclear envelope proteins in a patient with linear scleroderma. Proc Natl Acad Sci USA 1983; 80: 43748.
  • 16
    Lassoued K, Guilly M-N, Danon F et al. Antinuclear autoantibodies specific for lamins. Ann Int Med 1988; 108: 82933.
  • 17
    Worman HJ, Courvalin J-C. Autoantibodies against nuclear envelope proteins in liver disease. Hepatology 1991; 14: 126979.
  • 18
    Reeves WH, Chaudhary N, Salerno A, Blobel G. Lamin B autoantibodies in sera of certain patients with systemic lupus erythermatosus. J Exp Med 1987; 165: 75062.
  • 19
    Miyachi K, Shibata M, Onozuka Y, Kikuchi F, Imai N, Horigome T. Primary biliary cirrhosis sera recognize not only gp210 but also proteins of the p62 complex bearing N-acelylglucosamine residues from rat liver nuclear envelope. Mol Biol Rep 1996; 23: 22734.
  • 20
    Landay A, Jessop C, Lennette E, Levy J. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet 1991; 338: 70712.
  • 21
    Patarca R, Mark T, Fletcher M, Klimas N. Review. Immunology of chronic fatigue syndrome. J Chronic Fatigue Syndrome 2000; 6: 69107.
  • 22
    Hotopf M, David A, Hull L, Ismail K, Unwin C, Wessely S. Role of vaccinations as risk factors for ill health in veterans of the Gulf war: cross sectional study. B M J 2000; 320: 13637.
  • 23
    Ismail K, Everitt B, Blatchley N, Hull L, Unwin C, David A, Wessely S. Is there a Gulf war syndrome? Lancet 1999; 353: 17982.
  • 24
    Wessely S. Ten Years On, What Do We Know About the Gulf War Syndrome? Clin Med (JRCPL) 2001; 1: 2837.
  • 25
    Konstantinov K, Halberg P, Wiik A, Hoier-Madsen M, Wantzin P, Ullman S, Galcheva-Gargova Z. Clinical manifestation in patients with autoantibodies specific for nuclear lamin proteins. Clin Immunol Immunopathol 1992; 62: 1128.
  • 26
    Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes ‘susceptible’ mice resistant to Leishmania major. Science 1992; 257: 53942.
  • 27
    Hernandez-Pando R, Rook GA. The role of TNFα in T cell-mediated inflammation depends on the Th1/Th2 cytokine balance. Immunology 1994; 82: 5915.
  • 28
    Wu CY, Sarfati M, Heusser C, Fournier S, Rubio-Trujillo M, Peleman R, Delespesse G. Glucocorticoids increase the synthesis of immunoglobulin E by interleukin-4 stimulate human lymphocytes. J Clin Invest 1991; 87: 8707.
  • 29
    Brinkman V, Kristofic C. Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD4+ effector T cells generated from CD45RO- and CD45RO+ subsets. J Immunol 1995; 155: 33228.
  • 30
    Padgett DA, Sheridan JF, Loria R. Steroid hormone regulation of a polyclonal Th2 immune response. Ann NY Acad Sci 1995; 774: 3235.
  • 31
    Ramierz F, Fowell DJ, Puklavec M, Simmonds S, Mason D. Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J Immunol 1996; 156: 240612.
  • 32
    Munoz JJ, Peacock MG. Action of pertussigen (pertussis toxin) on serum IgE and on Fce receptors on lymphocytes. Cell Immunol 1990; 127: 32736.
  • 33
    Mu HH, Sewell WA. Enhancement of interleukin-4 production by pertussis toxin. Infect Immun 1993; 61: 283440.
  • 34
    Parker DC. T cell-dependent B cell activation. Ann Rev Immunol 1993; 11: 33160.
  • 35
    Tomer Y, Barak V, Gilburd B, Shoenfield Y. Cytokines in experimental autoimmune vasculitis: evidence for a Th2 type response. Clin Exp Rheumatol 1999; 17: 5216.
  • 36
    Ramanathan S, De Kozak Y, Saoudi A, Goureau O, Van der Meide PH, Druet P, Bellon B. Recombinant IL-4 aggravates experimental autoimmune uveoretinitis in rats. J Immunol 1996; 157: 220915.
  • 37
    Florquin S, Amraoui Z, Goldman M. Persistent production of Th2-type cytokines and polyclonal B cell activation after chronic administration of staphylococcal enterotoxin B in mice. J Autoimmun 1996; 9: 60915.DOI: 10.1006/jaut.1996.0080
  • 38
    Nishikai M, Tomomatsu S, Hankins RW, Takagi S, Miyachi K, Kosaka S, Akiya K. Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia: a possible marker for hypersomnia and cognitive disorders. Reumathol 2001; 40: 80610.
  • 39
    Bates DW, Buchwald D, Lee J et al. Clinical Laboratory Test Findings in Patients With Chronic Fatigue Syndrome. Arch Inter Med 1995; 155: 97103.
  • 40
    Itoh Y, Hamada H, Imai T, Seki T, Igarashi T, Yuge K, Fukunaga Y, Yamamoto M. Antinuclear antibodies in children with chronic nonspecific complaints. Autoimmunity 1997; 25: 24350.
  • 41
    Itoh Y, Igarashi T, Tatsuma N, Imai T, Yoshida J, Tsuchiya M, Murakami M, Fukunaga Y. Immunogenetic background of patients with autoimmune fatigue syndrome. Autoimmunity 2000; 32: 1937.
  • 42
    Centres for Disease Control Vietnam Experience Study. Health status of Vietnam veterans. II. Physical health. J Am Med Assoc 1988; 259: 270814.